Presentation of technical data on AAV and LNP for the development of biopharmaceuticals and gene therapy!
Quality assessment, which is crucial for the development of biopharmaceuticals and gene therapies, can be performed with this one device.
In the development of biopharmaceuticals and gene therapies, a lot is required for the evaluation of their characteristics, but particularly the assessment of stability is very important. Stunner is a device equipped with both UV/Vis and DLS that enables quality evaluation of proteins, AAV, adenoviruses, and LNPs in a low-volume and high-throughput manner. Moreover, it not only allows for measurements in a short time but also boasts high precision as one of its strengths. **Features of Stunner** - Measures 2μL, up to 96 samples in a single batch in 60 minutes **Applications** - AAV and adenovirus capsid titer - AAV and adenovirus empty/full ratio - Lipid nanoparticle (LNP) payload amount - Aggregation measurement - Concentration measurement - Sizing & polydispersity - B22 & kD *Download related materials now to check the details!*
basic information
【Specifications (Excerpt)】 ■Dimensions: Width 37 cm, Depth 54 cm, Height 33 cm, Weight 26 kg ■Electrical Characteristics: Universal input voltage 100–240 V AC, 50–60 Hz ■Computer: Separate computer with Windows 10 ■Connection: USB, TCP/IP (Service) ■Approvals: CE, FCC, CSA ■Regulatory Compliance: Optional 21 CFR Part 11 software package *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
Related Videos
catalog（13）
Download All Catalogs
News about this product（3）
-
We will exhibit at the Japanese Society of Gene and Cell Therapy Annual Meeting.
Our company will be exhibiting at the 28th Annual Meeting of the Japanese Society of Gene and Cell Therapy, which will be held from Thursday, July 14. At our booth, you can see devices such as the Stunner, which can measure AAV aggregation and Full/Empty ratios in high throughput, and the Uncle, which evaluates thermal stability such as aggregation, as well as videos and materials. We look forward to your visit.
-
I will be speaking at the BioPharma Online Conference 2022 Summer.
**Seminar Title** An Innovative Platform to Accelerate the Stability Evaluation of AAV Vectors **Overview** AAV is one of the viruses used in the development and basic research of gene therapy, but its characterization techniques require many considerations. In particular, stability evaluation is very important for ensuring safety. In this seminar, we will introduce a low-volume, high-throughput platform that accelerates stability evaluation, using AAV as an example.
-
[Free Webinar] Understanding the Characteristics Evaluation of Accelerated AAV from Research Papers
In the evaluation of AAV characteristics, there is always a demand for rapid responses regarding measurement criteria such as capsid titer, genome titer, Empty/Full ratio, aggregation, total protein amount, and DNA amount. By combining this data, we can understand what is happening during sample and process development. However, since there are many characterization analysis methods available, the key to success lies in how to select appropriate analytical tools and how much data can be interpreted from rare samples. In this webinar, we will explain how our Stunner technology can assist in rapid sample QC, optimization of downstream purification chromatography, and improvement of workflows for other common analytical assays. We will present case studies from actual paper data demonstrating how Stunner accelerates AAV characterization and saves both samples and time.
